Project co-funded by:
The project drugs2CAD is a co-promotion project established between CHEM4PHARMA and University of Coimbra (UC) with the aim of discovering new molecules that could be useful for the treatment of two important aging-associated diseases:
The CHEM4PHARMA/UC consortium has established a workplan based on the scientific expertize of its team members, with two parallel and complementary scientific approaches:
From the molecule to the target (preparation of a library of triterpenoids able to act in one or more targets)
From targets to molecules (computer-assisted rational drug design based on the macromolecular structure of the therapeutic target).
Project designation | Drugs2CAD
Project code | CENTRO-01-0247- FEDER-003269
Main Objective | OT1 - Reinforce research, technological development and innovation
Region of Intervention | Center (Centro)
Beneficiary entity | Chem4Pharma, LDA and University of Coimbra
Approval date | 26th February, 2016
Initiation date | 1st April, 2016
Conclusion date | 31st December, 2019
Total eligible cost | 483 424,92€
Incentive | 357 004.11 €
Financial support from the European Union | Project supported by CENTRO 2020 of PT2020 through the European Regional Development Fund (ERDF).